Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Kang, S
No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia
The FDA grants separate approvals for separate indications, which allows Novo Nordisk to market the same molecule under different names
The FDA is accepting comments on the rule until November 26, 2007
Neurotoxic effects of high-dose piperine on hippocampal synaptic transmission and synaptic plasticity in a rat model of memory impairment
doi:10.1038/s41598-024-53810-w
US$ 27.28
US$ 24.73
US$ 23.44
US$ 21.72
